EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides

Mikael Brink iD, Ewa Berglin iD, Aladdin J Mohammad iD, Anders Lundquist iD, Inger Gjertsson iD, Andrey Alexeyenko iD, Kristina Lejon iD, Solbritt Rantapää-Dahlqvist iD

Arthritis & Rheumatology · 2023-06 · 75 (6) · 996-1006

DOI: 10.1002/art.42425 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Arthritis & Rheumatology, online erschienen am 09.04.2023. Verfasst von Mikael Brink und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Medicine/Rheumatology, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Antibodies, Antineutrophil Cytoplasmic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Rheumatism Association, Umeå Universitet, Vasculitis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) is a chronic relapsing condition with unknown etiology. To gain insight into the molecular processes underlying the disease, we examined biomarkers in blood samples collected prior to symptom onset.

Methods

The National Patient Register and Cause of Death register were searched for AAV‐related International Classification of Diseases, Ninth Revision and Tenth Revision codes and linked to the registers from 5 biobanks. Eighty‐five AAV patients with samples predating symptom onset of AAV were identified. For each case of AAV, 2 matched controls were included. Proteinase 3 (PR3)–ANCA and myeloperoxidase (MPO)–ANCA expression levels were analyzed using enzyme‐linked immunosorbent assays. Using an Olink Inflammation panel, 73 of 92 proteins were included after quality control. Data were replicated in a second cohort of 48 presymptomatic individuals and 96 controls.

Results

Of the 20 proteins with the lowest P values in the original cohort, 7 were replicated in the second cohort and 5 proteins were found to be significant between the groups in a meta‐analysis. Eleven different pathways were identified in network enrichment analyses and were found to be significant in both cohorts. Stratification of samples obtained ≤5 years before symptom onset showed significant levels of CCL23, vascular endothelial growth factor A, and hepatocyte growth factor, which were also increased at borderline significant levels in the replication cohort (interleukin‐6 was found to be significantly increased in the replication cohort). In presymptomatic AAV patients, 6 proteins were associated with MPO‐ANCA positivity, and 7 proteins were associated with PR3‐ANCA positivity.

Conclusion

To our knowledge, this is the first study to identify protein markers preceding symptom onset in AAV patients. These findings set the stage for further research into the underlying cellular and molecular mechanisms in the pathogenesis of AAV and the diversification of patients into PR3‐ANCA+ and MPO‐ANCA+ subphenotypes. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Antineutrophil CytoplasmicAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisHumansMyeloblastinVascular Endothelial Growth Factor APeroxidase

Substanzen

Antibodies, Antineutrophil CytoplasmicMyeloblastinVascular Endothelial Growth Factor APeroxidase

Autor:innen und Institutionen

  • Department of Public Health and Medicine/Rheumatology, Umeå University, Umeå, Sweden.
  • Department of Clinical Sciences/Rheumatology, Lund University, Lund, Sweden, and Department of Medicine, University of Cambridge, Cambridge, UK.
  • Department of Statistics, Umeå University, Umeå, Sweden.
  • Department of Rheumatology and Inflammation Research, Gothenburg University, Gothenburg, Sweden.
  • Science for Life Laboratory, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, and Evi-networks, Stockholm, Sweden.
  • Department of Clinical Microbiology, Umeå University, Umeå, Sweden.

ORCID-Profile: Mikael Brink, Ewa Berglin, Aladdin J Mohammad, Anders Lundquist, Inger Gjertsson, Andrey Alexeyenko, Kristina Lejon, Solbritt Rantapää-Dahlqvist

Förderung

  • Swedish Rheumatism Association
  • Umeå Universitet
  • Vasculitis Foundation
  • Västerbotten County Council
  • Swedish Research Council

Zitieren

APA

Brink, M., Berglin, E., Mohammad, A. J., Lundquist, A., Gjertsson, I., Alexeyenko, A., Lejon, K., & Rantapää-Dahlqvist, S. (2023). Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides. Arthritis & Rheumatology, 75(6), 996-1006. https://doi.org/10.1002/art.42425

Vancouver

Brink M, Berglin E, Mohammad AJ, Lundquist A, Gjertsson I, Alexeyenko A, et al. Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides. Arthritis & Rheumatology. 2023;75(6):996-1006. doi:10.1002/art.42425

BibTeX
@article{Brink2023,
  author = {Brink, Mikael and Berglin, Ewa and Mohammad, Aladdin J and Lundquist, Anders and Gjertsson, Inger and Alexeyenko, Andrey and Lejon, Kristina and Rantapää-Dahlqvist, Solbritt},
  title = {Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  volume = {75},
  number = {6},
  pages = {996--1006},
  doi = {10.1002/art.42425}
}
Kostenlos starten →